TY - JOUR AB - Purpose Molecularly imprinted polymers (MIPs) have aroused focus in medicinal chemistry in recent decades, especially for biomedical applications. Considering the exceptional abilities to immobilize any guest of medical interest (antibodies, enzymes, etc.), MIPs is attractive to substantial research efforts in complementing the quest of biomimetic recognition systems. This study aims to review the key-concepts of molecular imprinting, particularly emphasizes on the conformational adaptability of MIPs beyond the usual description of molecular recognition. The optimal morphological integrity was also outlined in this review to acknowledge the successful sensing activities by MIPs.Design/methodology/approach This review highlighted the fundamental mechanisms and underlying challenges of MIPs from the preparation stage to sensor applications. The progress of electrochemical and optical sensing using molecularly imprinted assays has also been furnished, with the evolvement of molecular imprinting as a research hotspot.Findings The lack of standard synthesis protocol has brought about an intriguing open question in the selection of building blocks that are biocompatible to the imprint species of medical interest. Thus, in this paper, the shortcomings associated with the applications of MIPs in electrochemical and optical sensing were addressed using the existing literature besides pointing out possible solutions. Future perspectives in the vast development of MIPs also been postulated in this paper.Originality/value The present review intends to furnish the underlying mechanisms of MIPs in biomedical diagnostics, with the aim in electrochemical and optical sensing while hypothesizing on future possibilities. VL - 39 IS - 6 SN - 0260-2288 DO - 10.1108/SR-08-2018-0211 UR - https://doi.org/10.1108/SR-08-2018-0211 AU - Ang Qian Yee AU - Low Siew Chun PY - 2019 Y1 - 2019/01/01 TI - Feasibility study on molecularly imprinted assays for biomedical diagnostics T2 - Sensor Review PB - Emerald Publishing Limited SP - 862 EP - 873 Y2 - 2024/04/25 ER -